Document:

exv10w3

 

Exhibit 10.3

NONSTATUTORY STOCK OPTION AGREEMENT

                    , Optionee:

     Questcor Pharmaceuticals, Inc. (the “Company”), pursuant to its 2006 Equity Incentive Award
Plan (the “Plan”) has this day granted to you, the optionee named above, an option to purchase
shares of the common stock of the Company (“Common Stock”). This option is not intended to qualify
and will not be treated as an “incentive stock option” within the meaning of Section 422 of the
Internal Revenue Code of 1986, as amended (the “Code”).

     The grant hereunder is in connection with and in furtherance of the Company’s compensatory
benefit plan for participation of the Company’s employees (including officers), directors or
consultants. Any capitalized term not defined herein shall have the same meaning ascribed to it in
the Plan.

     The details of your option are as follows:

     1. The total number of shares of Common Stock subject to this option is                     
(                    ). Subject to the limitations contained herein, this option shall vest and be
exercisable beginning                      ___, 20___under the following schedule: 1/4th of the total
number of options will vest and be exercisable on the first (1st) anniversary of the date of this
Agreement. Thereafter, the remaining shares will vest at the rate of 1/48th of the
total options subject to this grant on each monthly anniversary of the date of this option grant.
Notwithstanding the foregoing, in the event of a Change in Control of the Company, then this option
shall become vested as provided in Section 12.2 of the Plan.

     2. (a) The exercise price of this option is                      ($___) per
share.

          (b) Payment of the exercise price per share is due in full in cash (including check)
upon exercise of all or any part of each installment which has become exercisable by you; provided,
however, that, if at the time of exercise, the Company’s Common Stock is publicly traded and quoted
regularly in the Wall Street Journal, payment of the exercise price, to the extent permitted by
applicable statutes and regulations, may be made by delivery of already-owned shares of Common
Stock, or a combination of cash and already-owned Common Stock. Such Common Stock (i) shall be
valued at its fair market value on the date of exercise, (ii) if originally acquired from the
Company, must have been held for the period required to avoid a charge to the Company’s reported
earnings, and (iii) must be owned free and clear of any liens, claims, encumbrances or security
interests.

1.

 

          (c) Notwithstanding the foregoing, this option may be exercised pursuant to a
program developed under Regulation T as promulgated by the Federal Reserve Board which results in
the receipt of cash (or check) by the Company prior to the issuance of Common Stock.

     3. The minimum number of shares with respect to which this option may be exercised
at any one time is one hundred (100), except (a) as to an installment subject to exercise, as set
forth in paragraph 1, which amounts to fewer than one hundred (100) shares, in which case, as to
the exercise of that installment, the number of such shares in such installment shall be the
minimum number of shares, and (b) with respect to the final exercise of this option this minimum
shall not apply. In no event may this option be exercised for any number of shares which would
require the issuance of anything other than whole shares.

     4. Notwithstanding anything to the contrary contained herein, this option may not be
exercised unless the shares issuable upon exercise of this option are then registered under the
Securities Act or, if such shares are not then so registered, the Company has determined that such
exercise and issuance would be exempt from the registration requirements of the Securities Act.

     5. The term of this option commences on the date hereof and, unless sooner
terminated as set forth below or in the Plan, terminates on                      (which date shall be no
more than                      (___) years from the date this option is granted). In no event may this option be
exercised after the date on which it terminates. This option shall terminate prior to the
expiration of its term as follows: ninety (90) calendar days after the termination of your
employment with the Company or an affiliate of the Company (as defined in the Plan) for any reason
or for no reason unless:

          (a) such termination of employment is due to your permanent and total disability
(within the meaning of Section 422(c)(6) of the Code), in which event the option shall terminate on
the earlier of the termination date set forth above or twelve (12) months following such
termination of employment;

          (b) such termination of employment is due to your death, in which event the option
shall terminate on the earlier of the termination date set forth above or twelve (12) months after
your death; or

          (c) during any part of such three (3) month period the option is not exercisable
solely because of the condition set forth in paragraph 4 above, in which event the option shall not
terminate until the earlier of the termination date set forth above or until it shall have been
exercisable for an aggregate period of three (3) months after the termination of employment; or

          (d) exercise of the option within three (3) months after termination of your
employment with the Company or with an affiliate would result in liability under section 16(b) of
the Exchange Act, in which case the option will terminate on the earlier of (i) the termination
date set forth above, (ii) the tenth (10th) day after the last date upon which exercise would
result in such liability or (iii) six (6) months and ten (10) days after the termination of your
employment with the Company or an affiliate.

2.

 

     However, this option may be exercised following termination of employment only as to that
number of shares as to which it was exercisable on the date of termination of employment under the
provisions of paragraph 1 of this option.

     6. (a) This option may be exercised, to the extent specified above, by
delivering a notice of exercise (in a form designated by the Company) together with the exercise
price to the Secretary of the Company, or to such other person as the Company may designate, during
regular business hours, together with such additional documents as the Company may then require.

          (b) By exercising this option you agree that:

               (i) the Company may require you to enter an arrangement providing for the cash
payment by you to the Company of any tax withholding obligation of the Company arising by reason
of: (1) the exercise of this option; (2) the lapse of any substantial risk of forfeiture to which
the shares are subject at the time of exercise; or (3) the disposition of shares acquired upon such
exercise; and

               (ii) the Company (or a representative of the underwriters) may, in connection with
the first underwritten registration of the offering of any securities of the Company under the Act,
require that you not sell or otherwise transfer or dispose of any shares of Common Stock or other
securities of the Company during such period (not to exceed one hundred eighty (180) days)
following the effective date (the “Effective Date”) of the registration statement of the Company
filed under the Act as may be requested by the Company or the representative of the underwriters;
provided, however, that such restriction shall apply only if, on the Effective Date, you are an
officer, director, or owner of more than one percent (1%) of the outstanding securities of the
Company. For purposes of this restriction you will be deemed to own securities which (i) are owned
directly or indirectly by you, including securities held for your benefit by nominees, custodians,
brokers or pledgees; (ii) may be acquired by you within sixty (60) days of the Effective Date;
(iii) are owned directly or indirectly, by or for your brothers or sisters (whether by whole or
half blood) spouse, ancestors and lineal descendants; or (iv) are owned, directly or indirectly, by
or for a corporation, partnership, estate or trust of which you are a shareholder, partner or
beneficiary, but only to the extent of your proportionate interest therein as a shareholder,
partner or beneficiary thereof. You further agree that the Company may impose stop-transfer
instructions with respect to securities subject to the foregoing restrictions until the end of such
period.

     7. This option is not transferable, except (i) by will or by the laws of descent and
distribution, or (ii) by written instruction, in a form accepted by the Company, to your spouse,
children, lineal ancestors and lineal descendants (or to a trust created solely for the benefit of
you and the foregoing persons) or to an organization exempt from taxation pursuant to Section
501(c)(3) of the Code or to which tax deductible charitable contributions may be made under Section
170 of the Code (excluding such organizations classified as private foundations under applicable
regulations and rulings), and is exercisable during your life only by you or a transferee
satisfying these conditions. Notwithstanding the foregoing, by delivering written notice to the
Company, in a form satisfactory to the Company, you may designate a third party who, in the event
of your death, shall thereafter be entitled to exercise this option.

3.

 

     8. This option is not an employment contract and nothing in this option shall be
deemed to create in any way whatsoever any obligation on your part to continue in the employ of the
Company, or of the Company to continue your employment with the Company. In the event that this
option is granted to you in connection with the performance of services as a consultant or
director, references to employment, employee and similar terms shall be deemed to include the
performance of services as a consultant or a director, as the case may be, provided, however, that
no rights as an employee shall arise by reason of the use of such terms.

     9. Any notices provided for in this option or the Plan shall be given in writing and
shall be deemed effectively given upon receipt or, in the case of notices delivered by the Company
to you, five (5) days after deposit in the United States mail, postage prepaid, addressed to you at
the address specified below or at such other address as you hereafter designate by written notice
to the Company.

     10. This option is subject to all the provisions of the Plan, a copy of which is
attached hereto and its provisions are hereby made a part of this option, and this option is
further subject to all interpretations, amendments, rules and regulations which may from time to
time be promulgated and adopted pursuant to the Plan. In the event of any conflict between the
provisions of this option and those of the Plan, the provisions of the Plan shall control.

     Dated the ___day of ___, 20___.

Very truly yours,

QUESTCOR PHARMACEUTICALS, INC.

	 	 	 	 	 	 	 
	 

	 	By:	 	 	 	 
	 

	 	 	 	 

	 	 
	 

	 	 	 	Duly authorized on behalf	 	 
	 

	 	 	 	of the Board of Directors	 	 

4.

 

The undersigned:

     (a) Acknowledges receipt of the foregoing option and the attachments referenced
therein and understands that all rights and liabilities with respect to this option are set forth
in the option and the Plan;

     (b) Acknowledges that as of the date of grant of this option, it sets forth the
entire understanding between the undersigned optionee and the Company and its affiliates regarding
the acquisition of stock in the Company and supersedes all prior oral and written agreements on
that subject with the exception of the following agreements only:

	 	 	 	 	 	 	 
	 

	NONE	 	 	 	 	 
	 

	 	 	 	 

	 	 
	 

	 	 	 	(Initial)	 	 

	 	 	 	 	 	 	 
	 

	 	OTHER	 	 	 	 
	 

	 	 	 	 	 	 
	 

	 	 	 	 	 	 
	 
	 
	 	 	 	 	 	 
	 

	 	 	 	 	 	 
	 
	 

	 	 	 	 	 	 
	 

	 	 	 	 	 	 

	 	 	 	 	 
	Optionee:
	 	 	 	 
	 

	 	 	 	 
	 

	 	 	 	 
	Address:
	 	 	 	 
	 

	 	 	 	 
	 
	 
	 	 	 	 
	 

	 	 	 	 
	 
	SS# / Tax ID
	 	 	 	 
	 

	 	 	 	 

Attachment:

     Form of Exercise

5.

 

NOTICE OF EXERCISE

Questcor Pharmaceuticals Inc.

			
	3260 Whipple Road
	 	Date of Exercise:                     
	Union City, California 94587	 	 

Ladies and Gentlemen:

     This constitutes notice under my stock option that I elect to purchase the number of shares
for the price set forth below.

	 	 	 	 	 	 	 	 	 
	Type of option (check one)	 	Incentive __      Nonstatutory __
	 
	 	 	 	 	 	 	 	 
	Stock option dated
	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	Stock option grant ID#
	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	Number of shares as
to which option is
exercised:
	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	Certificates to be
issued in name of:
	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	Total exercise price:
	 	$	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	+Cash payment delivered
herewith:
	 	$	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 

+All checks must be made payable to “Questcor Pharmaceuticals, Inc.”

By this exercise, I agree (i) to provide such additional documents as you may require pursuant to
the terms of the 2006 Equity Incentive Award Plan, (ii) to provide for the payment by me to you (in
the manner designated by you) of your withholding obligation, if any, relating to the exercise of
this option, and (iii) if this exercise relates to an incentive stock option, to notify you in
writing within fifteen (15) days after the date of any disposition of any shares of Common Stock
issued upon exercise of this option that occurs within two (2) years after the date of grant of
this option or within one (1) year after such shares of Common Stock are issued upon exercise of
this option.

Very truly yours,

                                                            

1.exv10w4

 

Exhibit 10.4

RESTRICTED STOCK AWARD AGREEMENT

     THIS RESTRICTED STOCK AWARD AGREEMENT (the “Agreement”) is entered into as of                     , 200_
by and between                      (hereinafter referred to as “Purchaser”) and Questcor Pharmaceuticals,
Inc., a California corporation (hereinafter referred to as the “Company”), pursuant to the
Company’s 2006 Equity Incentive Award Plan (the “Plan”). Any capitalized term not defined herein
shall have the same meaning ascribed to it in the Plan.

R E C I T A L S:

     A. Purchaser is an employee or director of the Company, and in connection therewith has
rendered services for and on behalf of the Company or any Subsidiary.

     B. The Company desires to issue shares of the Company’s Common Stock to Purchaser for the
consideration set forth herein to provide an incentive for Purchaser to remain in the service of
the Company and to exert added effort towards its growth and success.

     NOW, THEREFORE, in consideration of the mutual covenants hereinafter set forth, and for other
good and valuable consideration, the parties agree as follows:

          1. Issuance of Shares. The Company hereby offers to issue to Purchaser an aggregate
of                      (                    ) shares of Common Stock of the Company (the “Shares”) on the terms and
conditions herein set forth. Unless this offer is earlier revoked in writing by the Company,
Purchaser shall have ten (10) days from the date of the delivery of this Agreement to Purchaser to
accept the offer of the Company by executing and delivering to the Company two (2) copies of this
Agreement, without condition or reservation of any kind whatsoever, together with the consideration
to be delivered by Purchaser pursuant to Section 2 below, if applicable.

          2. Consideration. The purchase price for the Shares shall be                      ($                    ) per
share, or a total of                      ($                    ).

          3. Vesting of Shares. Subject to the limitations contained herein, the Shares shall
vest over a period of four years beginning                      ___, 20___under the following schedule: 1/4 of
the total number of Shares will vest on the first (1st ) anniversary of the date of this
Agreement. Thereafter, the remaining Shares will vest at the rate of 1/4th of the total Shares on
each subsequent anniversary of the date of this Agreement, such that all Shares shall be vested as
of the fourth (4th) anniversary of the date of this Agreement. Shares that are not
vested shall be referred to as “Unvested Shares.” Notwithstanding the foregoing, in the event of a
Change in Control of the Company, then the Shares shall become vested as provided in Section 12.2
of the Plan. No additional shares shall vest after the date of termination of Purchaser’s service
to the Company.

          4. Reconveyance Upon Termination of Service.

1

 

               (a) Repurchase Right. The Company shall have the right (but not the obligation) to repurchase
all or any part of the Unvested Shares (the “Repurchase Right”) in the event that the Purchaser’s
service to the Company terminates for any reason. Upon exercise of the Repurchase Right, the
Purchaser shall be obligated to sell his or her Unvested Shares to the Company, as provided in this
Section 4. If the Purchase Price paid for the Shares is zero, then upon termination of service
Purchaser shall be obligated to transfer his or her Unvested Shares to the Company without
consideration.

               (b) Consideration for Repurchase Right. The repurchase price of the Unvested Shares (the
“Repurchase Price”) shall be equal to the Purchase Price, if any, of such Unvested Shares.

               (c) Procedure for Exercise of Reconveyance Option. For sixty (60) days after the Termination
Date or other event described in this Section 4, the Company may exercise the Repurchase Right by
giving Purchaser and/or any other person obligated to sell written notice of the number of Unvested
Shares which the Company desires to purchase. The Repurchase Price for the Unvested Shares shall
be payable, at the option of the Company, by check or by cancellation of all or a portion of any
outstanding indebtedness of Purchaser to the Company, or by any combination thereof.

               (d) Notification and Settlement. In the event that the Company has elected to exercise the
Repurchase Right as to part or all of the Unvested Shares within the period described above and the
Company has previously issued certificates to Purchaser for the Shares, Purchaser or such other
person shall deliver to the Company certificate(s) representing the Unvested Shares to be acquired
by the Company within thirty (30) days following the date of the notice from the Company. The
Company shall deliver to Purchaser against delivery of the Unvested Shares, checks of the Company
payable to Purchaser and/or any other person obligated to transfer the Unvested Shares in the
aggregate amount of the Repurchase Price, if any, to be paid as set forth in paragraph 4(b) above.

               (e) Deposit of Unvested Shares. Purchaser shall deposit with the Company certificates
representing the Unvested Shares, together with a duly executed stock assignment separate from
certificate in blank, which shall be held by the Secretary of the Company. Purchaser shall be
entitled to vote and to receive dividends and distributions on all such deposited Unvested Shares.

               (f) Assignment. The Company may assign its Repurchase Right under this Section 4 without the
consent of the Purchaser.

          5. Restrictions on Unvested Shares. Unvested Shares may not be sold, transferred,
pledged, or otherwise disposed of, except that such Unvested Shares may be transferred to a trust
established for the sole benefit of the Purchaser and/or his or her spouse, children or
grandchildren. Any Unvested Shares that are transferred as provided herein remain subject to the
terms and conditions of this Agreement.

          6. Adjustments Upon Changes in Capital Structure. In the event that the outstanding
Shares of Common Stock of the Company are hereafter increased or decreased or changed into or
exchanged for a different number or kind of shares or other securities of the Company by reason of
a recapitalization, stock split, combination of shares, reclassification, stock

2

 

dividend, or other change in the capital structure of the Company, then Purchaser shall be
entitled to new or additional or different shares of stock or securities, in order to preserve, as
nearly as practical, but not to increase, the benefits of Purchaser under this Agreement, in
accordance with the provisions of Section 12.1 of the Plan. Such new, additional or different
shares shall be deemed “Shares” for purposes of this Agreement and subject to all of the terms and
conditions hereof.

          7. Shares Free and Clear. All Shares purchased by the Company (or otherwise returned
to the Company) pursuant to this Agreement shall be delivered by Purchaser free and clear of all
claims, liens and encumbrances of every nature (except the provisions of this Agreement and any
conditions concerning the Shares relating to compliance with applicable federal or state securities
laws), and the purchaser thereof shall acquire full and complete title and right to all of such
Shares, free and clear of any claims, liens and encumbrances of every nature (again, except for the
provisions of this Agreement and such securities laws).

          8. Limitation of Company’s Liability for Nonissuance; Unpermitted Transfers.

               (a) The Company agrees to use its reasonable best efforts to obtain from any applicable
regulatory agency such authority or approval as may be required in order to issue and sell the
Shares to Purchaser pursuant to this Agreement. The inability of the Company to obtain, from any
such regulatory agency, authority or approval deemed by the Company’s counsel to be necessary for
the lawful issuance and sale of the Shares hereunder and under the Plan shall relieve the Company
of any liability in respect of the nonissuance or sale of such Shares as to which such requisite
authority or approval shall not have been obtained.

               (b) The Company shall not be required to: (i) transfer on its books any Shares of the Company
which shall have been sold or transferred in violation of any of the provisions set forth in this
Agreement, or (ii) treat as owner of such shares or to accord the right to vote as such owner or to
pay dividends to any transferee to whom such shares shall have been so transferred.

          9. Notices. All notices, requests, demands and other communications required or
permitted under this Agreement shall be in writing and shall be deemed to have been duly given and
effective (i) when delivered by hand, (ii) when otherwise delivered against receipt therefor, or
(iii) three (3) business days after being mailed if sent by registered or certified mail, postage
prepaid, return receipt requested. Any notice shall be addressed to the parties as follows or at
such other address as a party may designate by notice given to the other party in the manner set
forth herein:

(a) if to the Company:

Questcor Pharmaceuticals, Inc.

3260 Whipple Road,

Union City, California, 94587,

Attention: Chief Financial Officer

                 (b) if to the Purchaser, at the address shown on the signature page of this Agreement or at
his most recent address as shown in the employment or stock records of the Company.

3

 

          10. Binding Obligations. All covenants and agreements herein contained by or on
behalf of any of the parties hereto shall bind and inure to the benefit of the parties hereto and
their permitted successors and assigns.

          11. Captions and Section Headings. Captions and section headings used herein are for
convenience only, and are not part of this Agreement and shall not be used in construing it.

          12. Amendment. This Agreement may not be amended, waived, discharged, or terminated
other than by written agreement of the parties.

          13. Entire Agreement. This Agreement and the Plan constitute the entire agreement
between the parties with respect to the subject matter hereof and supersede all prior or
contemporaneous written or oral agreements and understandings of the parties, either express or
implied.

          14. Assignment. Purchaser shall have no right, without the prior written consent of
the Company, to (i) sell, assign, mortgage, pledge or otherwise transfer any interest or right
created hereby, or (ii) delegate his or her duties or obligations under this Agreement. This
Agreement is made solely for the benefit of the parties hereto, and no other person, partnership,
association or corporation shall acquire or have any right under or by virtue of this Agreement.

          15. Severability. Should any provision or portion of this Agreement be held to be
unenforceable or invalid for any reason, the remaining provisions and portions of this Agreement
shall be unaffected by such holding.

          16. Counterparts. This Agreement may be executed in one or more counterparts, all of
which taken together shall constitute one agreement and any party hereto may execute this Agreement
by signing any such counterpart. This Agreement shall be binding upon Purchaser and the Company at
such time as the Agreement, in counterpart or otherwise, is executed by Purchaser and the Company.

          17. Applicable Law. This Agreement shall be construed in accordance with the laws of
the State of California without reference to choice of law principles, as to all matters,
including, but not limited to, matters of validity, construction, effect or performance.

          18. No Agreement to Employ. Nothing in this Agreement shall affect any right with
respect to continuance of employment by the Company or any of its subsidiaries. The right of the
Company or any of its subsidiaries to terminate at will the Purchaser’s employment at any time
(whether by dismissal, discharge or otherwise), with or without cause, is specifically reserved,
subject to any other written employment agreement to which the Company and Purchaser may be a
party.

          19. “Market Stand-Off” Agreement. Purchaser agrees that, if requested by the Company
or the managing underwriter of any proposed public offering of the Company’s securities (including
any acquisition transaction where Company securities will be used as all or part of the purchase
price), Purchaser will not sell or otherwise transfer or dispose of any Shares held by Purchaser
without the prior written consent of the Company or such underwriter, as the case may be, during
such period of time, not to exceed 180 days following the effective date of the registration

4

 

statement filed by the Company with respect to such offering, as the Company or the
underwriter may specify.

          20. Tax Elections. Purchaser understands that Purchaser (and not the Company) shall
be responsible for the Purchaser’s own tax liability that may arise as a result of the acquisition
of the Shares. Purchaser acknowledges that Purchaser has considered the advisability of all tax
elections in connection with the purchase of the Shares, including the making of an election under
Section 83(b) under the Internal Revenue Code of 1986, as amended (“Code”); Purchaser further
acknowledges that the Company has no responsibility for the making of such Section 83(b) election.
In the event Purchaser determines to make a Section 83(b) election, Purchaser agrees to timely
provide a copy of the election to the Company as required under the Code.

          21. Attorneys’ Fees. If any party shall bring an action in law or equity against
another to enforce or interpret any of the terms, covenants and provisions of this Agreement, the
prevailing party in such action shall be entitled to recover reasonable attorneys’ fees and costs.

[Signature Page Follows]

5

 

     IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above
written.

	 	 	 	 	 
	THE COMPANY:	 	PURCHASER:
	 
	 	 	 	 
	QUESTCOR PHARMACEUTICALS, INC.	 	 
	 
	 	 	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	By:
	 	 	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	 	 	 
	Name:

	 	 	 	[Print Name]
	 

	 	 	 	 
	 
	 	 	 	 
	Title:
	 	 	 	 
	 

	 	 	 	 
	 

	 	 	 	Address:
	 
	 	 	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 
	 

	 	 	 	 

6

 

CONSENT AND RATIFICATION OF SPOUSE

     The undersigned, the spouse of                                         , a party to the attached Restricted Stock
Award Agreement (the “Agreement”), dated as of                     , hereby consents to the execution of
said Agreement by such party; and ratifies, approves, confirms and adopts said Agreement, and
agrees to be bound by each and every term and condition thereof as if the undersigned had been a
signatory to said Agreement, with respect to the Shares (as defined in the Agreement) made the
subject of said Agreement in which the undersigned has an interest, including any community
property interest therein.

     I also acknowledge that I have been advised to obtain independent counsel to represent my
interests with respect to this Agreement but that I have declined to do so and I hereby expressly
waive my right to such independent counsel.

	 	 	 	 	 
	Date:
	 	 	 	 
	 

	 	 
	 	 
	 

	 	 	 	(Signature)
	 
	 	 	 	 
	 

	 	 	 	 
	 

	 	 	 	(Print Name)

7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00104-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00104-of-00352.parquet"}]]